財務情報
- Market Capitalization 2.89 B
- Employee 601
- Founded 2015
- CEO -
- Website www.arcusbio.com
- Headquarter Delaware, United States
- FIGI BBG00DQD26W3
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-7.24
売上高対価格比率
10.36
関連ティッカー
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 1634 | AMLX Amylyx Pharmaceuticals, Inc. - Common Stock | 27.23 USD | +1.42% | -1.84% | -18.03% | +86.51% | 3.03 B USD | ||
| 1652 | CELC Celcuity Inc. - Common Stock | 60.45 USD | -4.34% | -12.75% | -27.73% | +28.97% | 2.96 B USD | ||
| 1677 | DNLI Denali Therapeutics Inc. - Common Stock | 17.81 USD | -3.21% | -7.24% | -15.23% | +10.14% | 2.85 B USD | ||
| 1690 | ELVN Enliven Therapeutics, Inc. - Common Stock | 39.23 USD | -0.66% | -5.97% | -27.78% | +89.88% | 2.87 B USD |